InsidersTradesSigma
Browse the full record of transactions filed by Megna Michael R, Directeur Comptable. Insider active across 1 company, notably Kiniksa Pharmaceuticals, Ltd.. Cumulatively, 2 filings have been recorded. Activity tracked since 30 June 2020. The latest transaction was disclosed on 30 June 2020 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 de 2 declaraciones
Michael R. Megna is the Chief Accounting Officer at Kiniksa Pharmaceuticals, Ltd. He is responsible for managing accounting operations and financial compliance. Megna leverages his expertise to ensure the integrity of the company's financial reporting.